Regulations.gov document
Patent Extension Application from Ballard Spahr LLP on behalf of Revance Therapeutics Inc.
Other · FDA-2023-E-3109 · posted Aug 24, 2023
Key facts
| Document ID | FDA-2023-E-3109-0002 |
|---|---|
| Title | Patent Extension Application from Ballard Spahr LLP on behalf of Revance Therapeutics Inc. |
| Document type | Other |
| Subtype | Application |
| Agency | FDA |
| Docket | FDA-2023-E-3109 |
| Posted | Aug 24, 2023 |
| Comment period opens | Aug 24, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: